P/B Ratio (Price-to-Book Ratio) in Pharmaceuticals & Healthcare
How to interpret and apply p/b ratio (price-to-book ratio) specifically when analyzing pharmaceuticals & healthcare stocks in India.
Quick Recap: What is P/B Ratio (Price-to-Book Ratio)?
P/B ratio compares a stock's market price to its book value per share. It shows whether you're paying more or less than the company's net asset value.
P/B Ratio = Market Price per Share ÷ Book Value per Share
How P/B Ratio (Price-to-Book Ratio) Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
Typical P/E (related)20-40x
General benchmark: Banking: 1.5-3.0, Capital-intensive industries: 1.0-2.5
Example Pharmaceuticals & Healthcare Companies to Analyze
Use the Equiscale Screener → to filter pharmaceuticals & healthcare stocks by p/b ratio and other metrics.
Key Takeaways
- P/B Ratio (Price-to-Book Ratio) in pharmaceuticals & healthcare should be compared against sector peers, not the market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Always cross-check with other metrics. No single ratio tells the full story.